Gadi Riesenfeld

Director/Board Member at NUREXONE BIOLOGIC INC.

Net worth: - $ as of 30/04/2024

79 year

Health Technology

Consumer Services

Gadi Riesenfeld active positions

Companies	Position	Start	End
NUREXONE BIOLOGIC INC.	Director/Board Member	06/07/2023	-

Companies	Position	Start	End
W WORL	Chief Operating Officer	01/03/1992	01/11/2005
W WORL	President	01/03/1992	01/11/2005
Kamapharm Ltd.	Chief Executive Officer	01/03/1990	01/05/1991
Galisar Ltd.	Chief Executive Officer	01/05/1986	-
Otic Pharma Ltd. Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA.	Chairman	21/07/2009	-
	Founder	21/07/2009	-

The Hebrew University of Jerusalem

Doctorate Degree

International

Operational

Sectoral

Health Technology	4
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	2
W WORL	Health Technology
NUREXONE BIOLOGIC INC.	Health Technology

Private companies	3
Otic Pharma Ltd. Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA.	Health Technology
Kamapharm Ltd.
Galisar Ltd.